Thalys Medical Technology Group Corporation (SHA:603716)
23.56
-0.34 (-1.42%)
Mar 10, 2026, 10:15 AM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 4.93 billion as of March 9, 2026. Its market cap has increased by 179.19% in one year.
Market Cap
4.93B
Enterprise Value
5.33B
Revenue
1.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.56
Market Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 4.93B, an increase of 149.69%. That is a compound annual growth rate of 10.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SMO ClinPlus CO.,LTD. | 5.06B |
| Shanghai Labway Clinical Laboratory | 4.22B |
| Berry Genomics Co.,Ltd | 4.18B |
| Guangdong Hybribio Biotech | 4.14B |
| Medicalsystem Biotechnology | 3.92B |
| Cowealth Medical China | 6.80B |
| Maccura Biotechnology Co.Ltd | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 7.36B |